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Abstract
Background:  A variety of skin cancer susceptibility among mouse strains has allowed
identification of genes responsible for skin cancer development. Fifteen Skts loci for skin tumour
susceptibility have been mapped so far by using the two-stage skin carcinogenesis model [induced
by 7.12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)]. A few
responsible genes have been identified using wild-derived dominant resistant Mus spretus mice, and
one has been confirmed as a low penetrance cancer susceptibility gene in a variety of human
cancers.
Results: In the present study, we found that wild-derived PWK mice developed no tumour by
treatment with the two-stage skin carcinogenesis protocol. This phenotype is dominant resistant
when crossed with the highly susceptible strain FVB. By analyzing the F1 backcross generation
between PWK and FVB, we found empirical evidence of significant linkage at the new loci Skts-fp1
on chromosome 4 and suggestive linkage on chromosomes 1, 3, 11, 12 and 14 for skin tumour
susceptibility. Skts-fp1 includes the Skts7 interval, which was previously mapped by a Mus spretus
and NIH backcross. We also observed suggestive linkage on chromosomes 1 and 2 in the female
population only, while suggestive linkage on chromosomes 14 and 15 only was observed in the male
population. A significant genetic interaction was seen between markers of D11Mit339 and
D16Mit14.
Conclusion: Analysis of this new cross may facilitate the identification of genes responsible for
mouse skin cancer susceptibility and may reveal their biological interactions.
Background
Germ-line mutation has been reported in tumour sup-
pressor genes and in oncogenes that are responsible for
the highly penetrated familial cancer syndrome [1]. The
majority of cancers, however, are sporadic and often asso-
ciated with familial aggregation. Therefore, cancer suscep-
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tibility in general is explained by multiple low penetrance
cancer susceptibility genes [2,3].
Although analysis of the human population is useful in
finding the gene related to high penetrance disease, the
identification of low penetrance tumour susceptible genes
is still difficult. This is mainly due to heterogeneous
genetic background and complex environmental effects.
Mouse models of cancer have been used extensively for
the analysis and identification of the genetic components
of tumour susceptibility [4,5]. The susceptibility for the
two-stage skin carcinogenesis model varies among mouse
strains [6,7], and the genetic approach has been per-
formed to identify genes related to cancer susceptibility
[8-11]. Previous studies indicate that the percent contribu-
tion of skin cancer susceptibility can be explained by each
genetic component consisting of one of multiple loci and
their interaction [12]. Using NIH and Mus spretus crosses,
in which Mus spretus is dominant resistant against suscep-
tible Mus musculus strains, skin cancer susceptibility loci
Skts1~15 were mapped [8,9,12]. Psl1~4 were mapped by
using C57BL/6J(B6) and DBA crosses, in which DBA
shows semi-dominant susceptibility against resistant B6
[10,13]. Tomaso Dragani's group also mapped Skts1 using
Car-R and Car-S outbred. crosses [14], which were gener-
ated by balanced intercross of inbred strains, and reported
loss of tyrosinase activity conferred increased skin tumor
susceptibility [15]. Skts13 was identified as the Aurka gene
[16], and Skts14 was identified as Tgfb1 [11]. However,
none of the responsible genes have been cloned yet at the
remaining loci. Since functional polymorphisms of
AURKA were repeatedly reported to be determinants of
individual risk for colon, esophageal, skin, lung, breast,
ovarian, and prostate cancers in the human population
[16-19], identification of genetic components in the
mouse skin cancer susceptibility could facilitate the iden-
tification of candidate cancer risk factors in the human
population.
To narrow down the candidate loci and to identify the cor-
responding gene for the genetic components of mouse
skin cancer susceptibility, information from other strains
and crosses are valuable. In this study, we found that the
PWK strain, which is an inbred mouse derived from wild
Mus musculus musculus mice [20], is dominantly resistant
to chemically induced skin carcinogenesis when crossed
with a highly susceptible FVB strain. Because of the dom-
inant resistance and high genetic diversity between PWK
and FVB strains [21], we expected that there were multiple
genetic components involved in skin cancer susceptibility
as seen in our previous report of NIH/spretus cross. There-
fore, we performed genetic analysis of a large backcross
between PWK and FVB strains.
Results
Using the two stage skin tumour induction treatment, all
16 FVB mice developed papillomas with an average mul-
tiplicity of 32.56 ± 3.6, at 20 weeks after the initiation.
However, none of the 10 PWK/Rbrc mice developed any
papillomas on dorsal skin (Table 1). Also, none of the 17
(PWK/Rbrc × FVB/N)F1 mice, abbreviated as PF, devel-
oped tumours. Four out of the 25 (FVB/N × PWK/Rbrc)F1
mice, abbreviated as FP, developed tumours, but the aver-
age multiplicity was 0.32 ± 0.16 (Table 1). These results
demonstrate that the PWK strain has a dominant resistant
phenotype to the DMBA/TPA induced skin tumour
against a susceptible FVB strain.
Linkage analysis was performed by genotyping 208 F1
backcross mice (abbreviated as FPxF) for 204 polymor-
phic markers spread throughout the genome. The number
of papillomas 20 weeks after the initial treatment was
used as a trait. One hundred twenty three mice (56.7%)
developed papillomas, and average multiplicity was 4.86
± 0.56 (Table 1, Fig. 1). Males developed a significantly
higher number of papillomas than females. Even though
it was not significantly associated, FVB males also showed
higher multiplicity than FVB females. On the contrary,
only female mice developed papillomas in the F1 hybrids
(Table 1).
For parametric quantitative trait loci (QTL) regression
analysis, tumour multiplicity data are transformed by
root-square transformation to improve the fit of a nega-
tive binomial distribution pattern of nominal data sets to
a normal distribution [22]. By single point marker regres-
sion analysis, significant linkage with likelihood ratio sta-
tistics (LRS) larger than 12.9 was mapped only on
chromosome 4 (Table 2). LRS of at least 6.9 was consid-
ered evidence for suggestive linkage and was detected on
chromosomes 1, 3, 4, 11, 12 and 14. Interval mapping on
chromosome 4 showed highly significant linkage between
markers  D4Mit111  and  D4Mit308  (Skts-fp1). This QTL
interval covered almost one third of chromosome 4 and
there seem to be at least two peaks close to D4Mit26 and
D4Mit146 with values of LRS 38.5 and 40.5, respectively
(Fig. 2). It was estimated that approximately 18% of the
total trait variance would be explained by a QTL at this
locus.
The suggestive linkage on chromosomes 1, 2, 14 and 15
showed gender difference. Linkage on chromosomes 1
and 2 was observed only in female, and linkage on chro-
mosomes 14 and 15 was in males exclusively. Suggestive
evidence of linkage at loci on chromosome 1, 2, 14 and 15
was obtained with interval mapping in either male or
female population exclusively (Fig. 3A~D).BMC Genetics 2007, 8:39 http://www.biomedcentral.com/1471-2156/8/39
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To find interaction components among QTLs, a two-
dimensional scan of per-mutation test using J/qtl was per-
formed. With a standard criteria (Joint LOD>5 and [Epi-
static LOD > 3 or minimum LOD {locus1, locus2} >3]),
possible interactive QTL with epistatic LOD 4.14 was
found between markers D11Mit339 and D16Mit14. A plot
of the average number of papillomas of each genotype at
D11Mit339  and  D16Mit14  is shown in Fig. 4.
Homozygous FVB allele (FF) at the D16Mit14 marker is
associated with susceptibility if the genotype at the inter-
acting locus D11Mit339 is a homozygous (FF) genotype.
In the mice with heterozygous FP genotype at D16Mit14,
genotype at D11Mit339 had no association with the mul-
tiplicity of papillomas. Interval mapping indicated a
highly significant linkage Skts-fp2  (LRS 27.6) between
markers D11Mit155 and D11Mit178 locus in mice with FF
at D16Mit14, but no linkage was observed in mice with FP
at D16Mit14 (Fig. 5A). By interval mapping, significant
linkage  Skts-fp3  (LRS15.3) was also mapped between
markers D16Mit202 and D16Mit195 in mice with FF gen-
otype at D11Mit339 (Fig. 5B). Some weak linkage was
observed also in mice with FP at D11Mit339, however the
additive effect was opposite, i.e. PWK allele on
chromosome16 could be susceptible allele for skin tumor
development in FP at D11Mit339, while it is resistant in FF
at D11Mit339. Approximately 26% of the total trait vari-
ance would be explained by Skts-fp2 in mice with FF gen-
otype at D16Mit14 locus, and 14% for Skts-fp3 in mice
with FF genotype at D11Mit339. No sexual difference was
observed in Skts-fp2 and Skts-fp3.
Discussion
The present study indicates that PWK is a dominant resist-
ant strain to two-stage skin carcinogenesis, when crossed
with highly susceptible FVB mice. Among the 20 mice in
each group, no PWK developed papillomas, and only a
few FP F1 hybrid mice developed one papilloma. In a 208
backcross mice study, which should detect QTLs with
more than 4% variance, a significant QTL of Skts-fp1 has
been mapped. The linkage study using genetically and
phenotypically diverged strains FVB and PWK can facili-
tate analysis and understanding the genetic component of
this complex cancer susceptibility.
PWK is a wild-derived strain that could help ensure high
genetic diversity [21,23]. As seen in NIH and Mus spretus
inter-specific crosses, we expected to have a large genetic
variation to skin tumour susceptibility between FVB and
PWK. However, we mapped a significant locus on chro-
mosome 4 only. Interval mapping indicated that Skts-fp1
Distribution patterns of papilloma multiplicity Figure 1
Distribution patterns of papilloma multiplicity. The number 
of papillomas 20 weeks after the initiation is plotted as histo-
grams.
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Table 1: Incidence and multiplicity of papilloma in the parental strains, F1 and F1 backcross
Strain Animal No. Incidence (%) Multiplicity a)
FVB/N total 16 16 (100) 32.56 ± 3.60
female 9 9 (100) 28.22 ± 4.46
male 7 7 (100) 38.14 ± 5.36
PWK/Rbrc total 10 0 (0) 0
female 10 0 (0) 0
male 10 0 (0) 0
FVB × PWK total 25 4 (16) 0.32 ± 0.8
female 14 4 (28.6) 0.57 ± 1.01
male 11 0 (0) 0
PWK × FVB total 17 0 (0) 0
female 8 0 (0) 0
male 9 0 (0) 0
(FxP) × F total 208 123(56.7) 4.86 ± 0.56
female 107 60(56.1) 3.45 ± 0.64
male 101 63(62.4) 6.34 ± 0.92
a) data are shown as mean ± SEM.BMC Genetics 2007, 8:39 http://www.biomedcentral.com/1471-2156/8/39
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showed multiple significant peaks located between
D4Mit111 and D4Mit308, which covered almost one third
of chromosome 4, suggesting that a linkage group consist-
ing of multiple genes in a chromosome may be involved
in Skts-fp1. Contributions of the D4Mit26 locus and the
D4Mit146 locus (two major linkage peaks between which
recombination are observed in 16 mice) are estimated to
explain the approximately 15% and 18% of the variance
of PWK resistant phenotype, respectively. These contribu-
tions are higher than the contribution of major QTLs in
the NIH and Mus spretus backcross study, indicating that
contributions on a single chromosome are important in
the FVB and PWK cross. Linkage analysis also showed sug-
gestive linkage at loci on chromosomes 1, 3, 11, 12 and 14
in addition to significant linkage at D4Mit26  and
D4Mit167  (Skts-fp1). Although additional markers and
backcross mice are needed to hypothesize the multiple
genetic effects in this cross, it is possible that many other
weak loci and epistatic components contribute to the
resistant phenotype of PWK.
Skts7, which was mapped as a QTL on chromosome 4 for
chemically induced skin tumour susceptibility by the
analysis of the NIH/Ola and Mus spretus cross [8,9], is
located within Skts-fp1. A common gene may be responsi-
ble for the skin susceptibilities of the two crosses, segregat-
ing FVB with PWK and NIH with Mus spretus. So far, the
SNP information in the Phenome database is not suffi-
cient to find common haplotype blocks between PWK
and Mus spretus. However, after narrowing down the locus
and carrying out expression and functional analysis of the
candidate genes, we can perform a haplotype analysis
identifying a common polymorphism in the gene
between resistant strains (Mus spretus, PWK) and suscepti-
ble strains (NIH, and FVB). The haplotype analysis will
help to identify a candidate skin resistant gene.
Table 2: QTL for papilloma multiplicity
total female male
Number of papillomas c)
Marker Map location a) LRS P-value b) FF (Number of animals) FP (Number of animals) LRS P-value b) LRS P-value b)
Chromosome1
D1Mit18 21.4 7.4 0.00671* 6.33 ± 0.96 (103) 3.37 ± 0.56 (104) 8.9 0.00288* 0.9 >0.01
D1Mit284 35.6 6.8 0.00924 9.4 0.00219* 0.9 >0.01
D1Mit10 44.1 6.0 >0.01 8.4 0.00383* 0.7 >0.01
Chromosome2
D2Mit484 50 1.7 >0.01 8.1 0.00445* 0.2 >0.01
D2Mit401 58.1 5.2 >0.01 8.9 0.00289* 0.5 >0.01
D2Mit423 63.7 3.2 >0.01 8.8 0.00308* 0.0 >0.01
Chromosome3
D3mit40 36.1 7.6 0.0058* 6.39 ± 0.94 (109) 3.19 ± 0.54 (98) 3.6 >0.01 2.8 >0.01
Chromosome4
D4Mit235 3.3 7.4 0.00648* 6.56 ± 0.98 (98) 3.33 ± 0.57 (110) 4.1 >0.01
D4Mit93 16.1 11.0 0.00092* 6.55 ± 0.94 (99) 3.31 ± 0.60 (109) 10.4 0.00123* 3.2 >0.01
D4Mit111 22.1 12.5 0.00041* 6.57 ± 0.94 (99) 3.29 ± 0.61 (109) 8.8 0.00354* 4.8 >0.01
D4Mit26 36.3 34.4 <0.00001*** 7.94 ± 1.05 (95) 2.11 ± 0.39 (109) 16.5 0.00005** 18.7 0.00002**
D4Mit167 40 34.2 <0.00001*** 7.82 ± 1.01 (100) 2.11 ± 0.39 (108) 21.5 <0.00001*** 15.0 0.00011**
D4Mit308 51.9 19.9 0.00001** 6.72 ± 0.86 (100) 3.12 ± 0.69 (108) 11.6 0.00067* 10.1 0.00147*
Chromosome11
D11Mit339 33.8 8.3 0.00388* 6.36 ± 0.92 (99) 3.48 ± 0.65 (109) 3.3 >0.01 5.3 >0.01
Chromosome12
D12Mit283 9.4 7.8 0.00534* 6.24 ± 0.92 (107) 3.39 ± 0.60 (101) 2.5 >0.01 4.6 >0.01
D12Mit153 15.1 7.0 0.0081* 6.25 ± 0.93 (105) 3.44 ± 0.60 (102) 3.0 >0.01 3.3 >0.01
Chromosome14
D14Mit257 24.6 0.6 >0.01 9.4 0.00222*
D14Mit203 44.1 8.4 0.00382* 6.18 ± 0.89 (100) 3.63 ± 0.68 (108) 1.8 >0.01 5.9 >0.01
D14Mit193 48.3 12.3 0.00046* 6.43 ± 0.88 (103) 3.31 ± 0.67 (105) 1.8 >0.01 11.0 0.00089*
D14Mit195 60.3 8.0 0.00465* 5.96 ± 0.78 (107) 3.68 ± 0.81 (101) 1.5 >0.01 6.2 >0.01
D14Mit197 72.7 1.0 >0.01 8.0 0.00475*
Chromosome15
D15Mit15 64.9 3.4 >0.01 1.7 >0.01 10.6 0.0011*
D15Mit161 68.8 4.8 >0.01 0.2 >0.01 9.1 0.0026*
a) cM from the centrosome
b) P-value for the association at each locus
c) Data are shown as mean ± SEM.
Values in parenthesis are number of samples.
* Suggestive linkage
** Significant linkage
*** Highly Significant linkageBMC Genetics 2007, 8:39 http://www.biomedcentral.com/1471-2156/8/39
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From the study with Ornithine decarboxylase (Odc) trans-
genic BALB/cJ and C57BL/6J mice, significant linkage of
the skin tumour induced by DMBA and the Odc transgene
was detected in the interval between D4Mit31and
D4Mit52 (51.3–54.9 cM) [24]. These two strains may also
share a common resistant allele and could be used for
haplotype mapping to identify the candidate.
On this interval of Skts-fp1, many QTLs for susceptibility
to other types of tumours have been mapped [4,5]. Pctr1
and Pctr2 have been mapped as loci for susceptibility to
pristine induced plasmacytoma [25,26], and Cdkn2a has
been suggested to be a corresponding gene for
Pctr1[27,28]. Cdkn2a is also a strong candidate for Papg1,
QTL for progression of urethane induced lung tumours
[29]. The Cdkn2a locus encodes two tumour suppressors,
P16INK4a and P19ARF. There are no non-synonymous poly-
morphisms between FVB and PWK in ankirin 1 and 2
domains of P16INK4a, which are suggested to be corre-
sponding polymorphisms for Pctr1 and Papg1 (data not
shown). Because Figure 2 shows multiple peaks at the
Skts-fp1  locus on chromosome 4, as seen with other
tumour susceptibility QTLs [30], the locus is complex and
may create a linkage group containing two or more over-
lapping susceptibility and/or resistant regions. Thus, we
have initiated the creation of congenic mice containing
segments of the donor PWK allele on chromosome 4 to
the recipient FVB background.
Skts-fp2 on chromosome 11 was identified as a significant
linkage among FVB homozygous mice at marker
D16Mit14, but not in mice heterozygous at this locus.
Skts-fp3 on chromosome 16 was also identified among
FVB homozygous mice at the D11Mit339 locus, but not in
mice with heterozygous at this locus. Our results suggest
that Skts-fp2 and Skts-fp3 showed the evidence of interac-
tion. An interaction component between two loci has
been suggested to play an important role in cancer suscep-
tibility [4,12] and recently Tgfb1 was indicated as a corre-
sponding gene for a skin tumour susceptible locus Skts14.
This locus was shown to have interaction with Skts15,
which overlaps with the Tgfbm3 locus mapped as Tgfb1
modifier locus [11]. Skts-fp2 could also be functionally
related to Skts-fp3. Scc15, the QTL for 1,2-dimethylhydra-
zine induced colon tumour susceptibility in mice [31] and
Sluc4, the QTL for N-ethyl-N-nitrosourea induced lung
tumour in mice [32] have been mapped around the Skts-
fp2  locus, but no QTL for skin tumor susceptibility is
mapped at this locus. No QTL for susceptibility to skin
cancer or other types of tumour has been mapped around
the Skts-fp3 locus, however Skts9 for DMBA/TPA induced
skin cancer [9] and Sluc27  for N-ethyl-N-nitrosourea
induced lung tumour [33] are mapped on the same chro-
mosome. If extreme phenotypic differences exist between
two strains and dominant interactions are expected, the
interaction components can be detected more efficiently
using a simple backcross [12]. Although further analysis
with an additional number of mice is needed to identify
responsible genes at the interactedlocus and significant
interaction component between two QTLs, the genetic
interaction between Skts-fp2 and Skts-fp3 reveals a biolog-
ical interaction of genes at two loci.
In this study, we found that linkages at four loci show sex-
ual difference. Suggestive linkage on chromosomes 1 and
2 was exclusively observed in females and suggestive link-
age on chromosomes 14 and 15 was observed only in
males. Usually this kind of study is performed with either
all female or all male animals, and sexual differences in
tumour susceptibility genes are not identified. An
increased number of mice will enable us to reveal the QTL
for tumour susceptibility, which interacts with sex chro-
mosomes directly or indirectly.
The absence of PWK alleles at both markers remarkably
increased the average number of papillomas, whereas no
effect was seen in animals that retained one PWK allele at
either locus. A dominant resistant to cancer development
may be redundant regulation. Candidate accessory regula-
tory genes modify a major effect gene and can be identi-
fied as a dominant interacted modifier. Although
individual modifying genes may show only subtle quanti-
tative effects on tumourigenesis, combinations of sup-
pressive alleles can completely eliminate neoplasia. The
Interval mapping on chromosome 4 Figure 2
Interval mapping on chromosome 4. The QTL on chromo-
some 4 shows significant linkage to multiplicity of papilloma 
20 weeks after the initiation. Black line indicates the linkage 
calculated for whole mice, right gray is for female mice, dark 
gray is for male mice. Genetic distances of each marker from 
centrosome are indicated as genetic position (cM) on the 
bottom.
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R
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identification of effective combinations of gene activities
reflects the general finding of "genetic redundancy", in
which the loss of function of a single gene has no obvious
phenotype.
Here we present three significant loci related to skin
tumour susceptibility from the analysis of a new strain
combination of FVB and PWK. Among previous studies
using other tumour induction systems, many tumour sus-
ceptible loci mapped on the same chromosomal regions
where skin cancer susceptibility loci were mapped. For
example,  Psl2  was mapped close to Skts13,  Psl3  was
mapped close to Skts8, and the locus found from the anal-
ysis of Car-S and Car-R strains was located on the Skts1
locus. Also, Skts-fp1 identified in this study covered the
region on which Skts7  and the linkage obtained from
ODC transgenic mice have been mapped. As described in
the studies for in silico mapping methods using many
inbred strains, congenic, recombinant inbred, advanced
intercross, chromosome substitution strains or very
recently collaborative crosses [34-36], it is obvious that
accumulated information from several genetic analyses
using many other strains provides an important and rapid
route to identification of complex germ-line genetic vari-
ants that confer increased cancer risk.
Conclusion
This study shows that PWK is a dominant resistant strain
to two-stage skin carcinogenesis when it is crossed with
the FVB strain. By linkage analysis using backcross
between FVB and PWK, three significant QTLs, Skts-fp1,
Skts-fp2 and Skts-fp3, for the skin tumour susceptibility
Interval mapping on chromosome 1, 2, 14 and 15 Figure 3
Interval mapping on chromosome 1, 2, 14 and 15. Result of interval mapping on (A) chromosome 1, (B) chromosome 2, (C) 
chromosome 14 and (D) chromosome 15 are shown. Right gray line indicates the linkage for female mice and dark gray line for 
male mice. Genetic distances of each marker from centrosome are indicated as the genetic position (cM) on the bottom.
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locus were mapped. Studies using this new cross could be
an efficient method for finding new genes responsible for
skin cancer susceptibility and for examining genetic/bio-
logical interaction between the responsible genes.
Methods
Animals
Mice used in this study were bred in the SPF Facility in the
Department of Laboratory Animals at Roswell Park Can-
cer Institute and are treated in accordance with IACUC
regulations. FVB/N mice were purchased from TACONIC
(Germantown, NY). PWK/Rbrc inbred mice were
obtained from RIKEN BRC (Ibaraki, Japan). Twenty five
(FVB/N × PWK/Rbrc) F1 and 17 (PWK/Rbrc × FVB/N) F1,
abbreviated as FP and PF respectively, were generated
from the two strains of mice. FP mice were then back-
crossed with FVB/N to generate 208 F1 backcross animals.
Skin cancer induction
7.12-Dimethylbenz(a)anthracene (DMBA) and 12-O-tet-
radecanoylphorbol-13-acetate (TPA) were purchased
from Sigma Chemical Co. (St. Louis, MO). DMBA is used
as a carcinogen and TPA as a promoter.
Nine of FVB female and 7 of male mice, each 10 female
and 10 male of PWK mice, 14 female and 11 male of FP
hybrids, 8 female and 9 male of PF mice, 107 female and
101 male of FPxF backcross mice were applied for skin
carcinogen.
At 8–11 weeks of age, the back skin of each mouse was
carefully shaved with an electric clipper. Two days after
shaving, 200 ul of DMBA (0.125 mg/ml) was dissolved in
acetone and applied to the back of each mouse prior to
the hair growth cycle. A total of 97.4 nmol of DMBA was
applied to each mouse. One week after the treatment,
mice received 400 ul of TPA (5 × 10-5 M solution in ace-
tone) as a promoter, i.e., 32.4 nmol of TPA, twice weekly
for 20 weeks. Animals are assessed twice weekly for the
appearance of papillomas during the promotion phase.
The number of papillomas was counted every other week
until 20 weeks after tumour initiation. Papilloma inci-
dence during the promotion phase and papilloma multi-
plicity 20 weeks after the initiation was used for
assessment of skin tumour susceptibility in this study.
Genotype
Genomic DNA was isolated from mouse tails using the
alkali method. Briefly, 1~2 mm of tails were boiled in 300
ul of 50 mM NaOH for 30 min, then 25 ul of 1 M Tris-
HCL (ph8.0) was added. DNAs were then genotyped for
204 polymorphic microsatellite markers spaced at
approximately 8-cM intervals through chromosome 1 to
19 and X by polymerase chain reaction (PCR). Informa-
tion of MIT markers used in this study is available upon
request. PCR reactions were carried out using a Biometlar
thermocyler, and PCR products were separated by electro-
phoresis through 4% Nusieve-GTG low melting tempera-
ture agarose gels (FMC) in the 0.5 × TBE buffer.
Statistical analysis
MapManager QTX ver1.03 [37,38] was used to analyse
phenotype and genotype data to map QTLs related to sus-
ceptibility for chemically induced skin tumours. Permuta-
tion tests were performed for FPxF F1 backcross
generation, to estimate empirical threshold values for
quantitative trait mapping. Single-point marker regres-
sion was performed for the whole chromosomes to find
linkage, and then interval mapping was performed to ana-
lyse the chromosome with significant linkage in the single
point marker regression. A permutation test (10,000 per-
mutations at a 1 cM interval) was performed, and the sig-
nificance threshold was calculated to establish the
empirical significance levels in QTL mapping experi-
ments. Suggestive (LRS > 6.9), significant (LRS > 12.9),
highly significant (LRS > 20.8) thresholds were estab-
lished and used for present analysis. A two-dimensional
genome scan using J/qtl [39,40] was performed to analyse
interactions between QTLs.
Allelic interaction between D11Mit339 and D16Mit14 Figure 4
Allelic interaction between D11Mit339 and D16Mit14. Asso-
ciation between D11Mit339 genotype and multiplicity of pap-
illoma 20 weeks after the initiation is shown. Black square 
indicates the mice with FF genotype at the D16Mit14 locus. 
White square indicates the mice with FP genotype at the 
D16Mit14 locus. Data are shown as mean ± SEM.
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